Видео ютуба по тегу Speaker: Messoud Ashina

From Pathophysiology to Drug Discovery in Migraine | Prof. Messoud Ashina | ICAMS 2022
From Pathophysiology to Drug Discovery in Migraine | Prof. Messoud Ashina | ICAMS 2022
Editor's Choice Cephalalgia Episode 2 - Interview with Professor Messoud Ashina
Editor's Choice Cephalalgia Episode 2 - Interview with Professor Messoud Ashina
BKCa channels: potential novel anti-migraine target
BKCa channels: potential novel anti-migraine target
PACAP as a Future Migraine Treatment Target
PACAP as a Future Migraine Treatment Target
PROMISE-1: eptinezumab in episodic migraine
PROMISE-1: eptinezumab in episodic migraine
PEARL study: fremanezumab for chronic or episodic migraine in the real world
PEARL study: fremanezumab for chronic or episodic migraine in the real world
1st Azerbaijan Neuroscience Conference - Highlights
1st Azerbaijan Neuroscience Conference - Highlights
The evolving migraine prevention landscape: EAN 2020 highlights
The evolving migraine prevention landscape: EAN 2020 highlights
The burden of migraine: from individuals to society
The burden of migraine: from individuals to society
IHC 2023 - congress highlights
IHC 2023 - congress highlights
Avatars help schizophrenia patients silence tormenting voices - futuris
Avatars help schizophrenia patients silence tormenting voices - futuris
THE BRAIN CONFERENCE 2022: Headache & Pain Session
THE BRAIN CONFERENCE 2022: Headache & Pain Session
Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine
Real-world studies show effectiveness of anti-CGRP mAbs in difficult to treat patients with migraine
PACAP as a future target for anti-migraine medication
PACAP as a future target for anti-migraine medication
Лечение менструальной мигрени | Treatment of Menstrual Migraine
Лечение менструальной мигрени | Treatment of Menstrual Migraine
Headache Update Webinar, 05 June 2021 Advancements in the management and prevention of Migraine.
Headache Update Webinar, 05 June 2021 Advancements in the management and prevention of Migraine.
Latest guidelines on anti-CGRP antibodies: first-line and long-term use
Latest guidelines on anti-CGRP antibodies: first-line and long-term use
Anti-CGRP monoclonal antibodies for difficult to treat migraines: DELIVER trial
Anti-CGRP monoclonal antibodies for difficult to treat migraines: DELIVER trial
INTERNATIONAL CONFERENCE „ Update on chronic headache and pain”
INTERNATIONAL CONFERENCE „ Update on chronic headache and pain”